The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance.
暂无分享,去创建一个
[1] E. Threlfall,et al. Ciprofloxacin-resistant Salmonella typhi in the UK , 1995, The Lancet.
[2] R. Anderson,et al. Effect of a commercial competitive exclusion culture (Preempt) on mortality and horizontal transmission of Salmonella gallinarum in broiler chickens. , 1998, Avian diseases.
[3] S. Levy,et al. Purification of the Tn 10‐specified tetracycline efflux antiporter TetA in a native state as a polyhistidine fusion protein , 1996, Molecular microbiology.
[4] J. Cove,et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. , 1996, The Journal of antimicrobial chemotherapy.
[5] S. Gorbach. Efficacy of Lactobacillus in Treatment of Acute Diarrhea , 1996 .
[6] N. Akimitsu,et al. Increase in Resistance of Methicillin-ResistantStaphylococcus aureus to β-Lactams Caused by Mutations Conferring Resistance to Benzalkonium Chloride, a Disinfectant Widely Used in Hospitals , 1999, Antimicrobial Agents and Chemotherapy.
[7] S. Levy,et al. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. , 1976, The New England journal of medicine.
[8] S. Levy,et al. The challenge of antibiotic resistance. , 1998, Scientific American.
[9] S. Levy. Antibacterial household products: cause for concern. , 2001, Emerging infectious diseases.
[10] S. Levy. The Antibiotic Paradox , 1992, Springer US.
[11] S. Solter,et al. Antibiotic Use and Abuse Among Physicians in Private Practice in Shiraz, Iran , 1975, Medical care.
[12] S. Levy,et al. Antibiotic and antiseptic resistance: impact on public health , 2000, The Pediatric infectious disease journal.
[13] P. Bullough,et al. The quarternary molecular architecture of TetA, a secondary tetracycline transporter from Escherichia coli , 2000, Molecular microbiology.
[14] D. Chadwick,et al. Ciba Foundation Symposium 207 - Antibiotic Resistance: Origins, Evolution, Selection and Spread , 1997 .
[15] S. Levy,et al. The NH2-terminal Half of the Tn10-specified Tetracycline Efflux Protein TetA Contains a Dimerization Domain (*) , 1995, The Journal of Biological Chemistry.
[16] S. Levy,et al. The impact of antibiotic use on resistance development and persistence. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[17] S. Levy. Antibiotic resistance: an ecological imbalance. , 2007, Ciba Foundation symposium.
[18] A. D. Russell,et al. Possible Link between Bacterial Resistance and Use of Antibiotics and Biocides , 1998, Antimicrobial Agents and Chemotherapy.
[19] S. Levy,et al. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. , 1998, FEMS microbiology letters.
[20] N. Datta,et al. R Factors in Escherichia coli in faeces after oral chemotherapy in general practice. , 1971, Lancet.
[21] S. Levy,et al. Triclosan targets lipid synthesis , 1998, Nature.
[22] H. Schweizer,et al. Cross-Resistance between Triclosan and Antibiotics inPseudomonas aeruginosa Is Mediated by Multidrug Efflux Pumps: Exposure of a Susceptible Mutant Strain to Triclosan Selects nfxB Mutants Overexpressing MexCD-OprJ , 2001, Antimicrobial Agents and Chemotherapy.
[23] J. Lederberg,et al. Antimicrobial resistance : issues and options : workshop report , 1998 .
[24] S. Levy. Antibiotic resistance: consequences of inaction. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] S. Levy,et al. Reversal of Tetracycline Resistance Mediated by Different Bacterial Tetracycline Resistance Determinants by an Inhibitor of the Tet(B) Antiport Protein , 1999, Antimicrobial Agents and Chemotherapy.
[26] J. Møller,et al. Changing Patterns of Plasmid-Mediated Drug Resistance During Tetracycline Therapy , 1977, Antimicrobial Agents and Chemotherapy.